Search company, investor...

Predict your next investment

Corporation
HEALTHCARE | Medical Devices & Equipment / Other Medical Devices
demant.com

See what CB Insights has to offer

Investments

2

Partners & Customers

3

Service Providers

1

About Demant

Demant, fka William Demant, is a global company that develops, manufactures, and sells hearing instruments, hearing implants, diagnostic instruments, and personal communication devices. William Demant Invest, wholly owned by the Oticon Foundation, holds the majority of shares in William Demant Holding, the company behind the commercial successes of such brands as Oticon, Bernafon, Sonic, Oticon Medical, Maico, Interacoustics, Grason-Stadler and Sennheiser Communications.

Headquarters Location

Kongebakken 9

Smorum, 2765,

Denmark

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Demant Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Demant Rank

Latest Demant News

Hearing implant merger ‘could lead to higher prices for NHS’, watchdog warns

Dec 6, 2022

The UK competition watchdog has warned that a merger of two hearing implant firms “could lead to higher prices for the NHS”. The Competition and Markets Authority (CMA) said Cochlear’s proposed purchase of Oticon Medical, the hearing division of Danish firm Demant, could also reduce quality and slow innovation for patients in the UK. Australia-based Cochlear agreed the deal to buy Oticon for 850 million Danish krona (£98 million) in April. Both firms supply cochlear implants and bone conduction technology, which are surgically implanted hearing devices. We need your consent to load this Social Media content We use a number of different Social Media outlets to manage extra content that can set cookies on your device and collect data about your activity. Please review their details and accept them to load the content. Manage Preference During an initial phase 1 investigation into the deal, the CMA found that the merger deal would result in the new operation controlling between 90% and 100% of the bone conduction solutions market in the UK. The watchdog said it is therefore “concerned” that the elimination of Cochlear’s biggest competitor could result in less choice and higher pricing. The CMA said the two firms have until December 13 to offer potential undertakings to allay these concerns. If these concerns are not addressed, the regulator will take the proposed merger to a more thorough phase 2 probe. Sorcha O’Carroll, CMA senior director of mergers, said: “We’re concerned that this deal could lead to higher costs for the NHS and worse outcomes for patients who rely on life-changing hearing implants. “The merger will wipe out one of the main suppliers and leave Cochlear with a near monopoly in the supply of bone conduction implants. “Healthy competition in the medical technology sector is central to continued innovation, more choice and improvements in patient treatments.” Cochlear and Demant have been contacted for comment. Daily Headlines & Evening Telegraph Newsletter Receive today's headlines directly to your inbox every morning and evening, with our free daily newsletter. Enter email address

Demant Investments

2 Investments

Demant has made 2 investments. Their latest investment was in ShengWang as part of their Corporate Minority on March 3, 2022.

CBI Logo

Demant Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

3/4/2022

Corporate Minority

ShengWang

Yes

1

2/3/2020

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/4/2022

2/3/2020

Round

Corporate Minority

Series A

Company

ShengWang

Subscribe to see more

Amount

$99M

New?

Yes

Subscribe to see more

Co-Investors

Sources

1

10

Demant Acquisitions

2 Acquisitions

Demant acquired 2 companies. Their latest acquisition was ShengWang on June 14, 2022.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

6/14/2022

Other

$99M

Acquired

1

9/18/2015

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/14/2022

9/18/2015

Investment Stage

Other

Companies

Subscribe to see more

Valuation

$99M

$99M

Total Funding

Note

Acquired

Subscribe to see more

Sources

1

10

Demant Partners & Customers

3 Partners and customers

Demant has 3 strategic partners and customers. Demant recently partnered with Ear Science Institute Australia on February 2, 2021.

Date

Type

Business Partner

Country

News Snippet

Sources

2/24/2021

Client

Australia

Research giants join forces for hearing impaired

The partnership with William Demant Foundation will further provide Ear Science Institute Australia and Curtin University with access to applied research expertise in hearing , cognition and signal processing from Oticon and Oticon , an industry leader in hearing loss care and research .

1

8/3/2018

Partner

Netherlands

Subscribe to see more

Subscribe to see more

10

Partner

Germany

Subscribe to see more

Subscribe to see more

10

Date

2/24/2021

8/3/2018

Type

Client

Partner

Partner

Business Partner

Country

Australia

Netherlands

Germany

News Snippet

Research giants join forces for hearing impaired

The partnership with William Demant Foundation will further provide Ear Science Institute Australia and Curtin University with access to applied research expertise in hearing , cognition and signal processing from Oticon and Oticon , an industry leader in hearing loss care and research .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

Demant Service Providers

1 Service Provider

Demant has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Acquired

Investment Bank

Financial Advisor

Service Provider

Associated Rounds

Acquired

Provider Type

Investment Bank

Service Type

Financial Advisor

Partnership data by VentureSource

Demant Team

4 Team Members

Demant has 4 team members, including current President, Arne Boye Nielsen.

Name

Work History

Title

Status

Arne Boye Nielsen

President

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Arne Boye Nielsen

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

President

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.